These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacologic properties of a new oral contrast medium for cholecystography. Rosati G; De Micheli P; Schiantarelli P Acta Radiol Diagn (Stockh); 1972 May; 12(3):335-46. PubMed ID: 5045427 [No Abstract] [Full Text] [Related]
4. The effect of diet and fasting on gallbladder opacification during oral cholecystography in dogs as measured by computed tomography. Fon GT; Hunter TB; Berk RN; Capp MP Radiology; 1980 Sep; 136(3):585-92. PubMed ID: 7403534 [TBL] [Abstract][Full Text] [Related]
5. [Clinical and chemical aspects of residual contrast media in the intestine during oral cholecystography with Trijobil and Falignost]. Quasdorf M; Becker C; Quasdorf G; Becker HW Radiol Diagn (Berl); 1977; 18(1):19-28. PubMed ID: 866607 [No Abstract] [Full Text] [Related]
6. Single dose oral cholecystography. Krook PM; Bush WH Radiology; 1978 Jun; 127(3):643-4. PubMed ID: 663149 [TBL] [Abstract][Full Text] [Related]
7. Determinants of the rate of intestinal absorption of oral cholecystographic contrast agents in the dog jejunum. Janes JO; Dietschy JM; Berk RN; Loeb PM; Barnhart JL Gastroenterology; 1979 May; 76(5 Pt 1):970-7. PubMed ID: 155546 [TBL] [Abstract][Full Text] [Related]
8. [On problems of dosage and application for peroral cholecystography with falignost (author's transl)]. Voigt A Radiol Diagn (Berl); 1977; 18(5):673-7. PubMed ID: 607265 [No Abstract] [Full Text] [Related]
9. Double-blind study of four oral cholecystographic preparations. Parks RE Radiology; 1974 Sep; 112(3):525-8. PubMed ID: 4602064 [No Abstract] [Full Text] [Related]
10. [Effects of three oral cholecystographic agents on laboratory data. Clinical chemical determinations and urinary tests (author's transl)]. Kasezawa N; Tazawa R; Urushibata S; Kobayashi M Rinsho Byori; 1974 Jun; 22(6):440-4. PubMed ID: 4472714 [No Abstract] [Full Text] [Related]
11. Time of optimal gallbladder opacification with bilopaque (tyropanoate sodium). Oliphant M; Whalen JP; Evans JA Radiology; 1974 Sep; 112(3):531-2. PubMed ID: 4843281 [No Abstract] [Full Text] [Related]
12. Radiopaque contrast media. XXXV - Physical properties of iopronic acid, a new oral cholecystographic agent. Felder E; Pitre D; Grandi M Farmaco Sci; 1976 Jun; 31(6):426-37. PubMed ID: 1278362 [TBL] [Abstract][Full Text] [Related]
13. Biliary excretion of three cholecystographic contrast agents in dogs: iocetamic acid, iopronic acid and iosumetic acid. Barnhart JL; Berk RN; Czuleger PC Invest Radiol; 1979; 14(1):79-87. PubMed ID: 158000 [No Abstract] [Full Text] [Related]
14. [Synthesis of 1-(4-iodophenyl)-3-hydroxypyridazone-6 derivatives]. Baloniak S; Thiel U; Pacholczyk M Acta Pol Pharm; 1976; 33(1):73-9. PubMed ID: 1266646 [No Abstract] [Full Text] [Related]
15. [Initial experience with the Soviet preparation, biloptin, for oral cholecystocholangiography]. Popova ZP; Ushakov VL; Sviridov NK Vestn Rentgenol Radiol; 1979; (2):23-7. PubMed ID: 375563 [No Abstract] [Full Text] [Related]
16. Comparison of the opacifying characteristics and pharmacologic responses of iocetamic acid (Cholebrine), a new oral cholecystographic agent, with sodium tyropanoate (Bilopaque). Wishart DL; Dotter CT Am J Roentgenol Radium Ther Nucl Med; 1973 Oct; 119(2):429-32. PubMed ID: 4748234 [No Abstract] [Full Text] [Related]
17. Prebiotic synthesis of hydrophobic and protein amino acids. Ring D; Wolman Y; Friedmann N; Miller SL Proc Natl Acad Sci U S A; 1972 Mar; 69(3):765-8. PubMed ID: 4501592 [TBL] [Abstract][Full Text] [Related]
18. [Oral gallbladder contrast agents in liver damage]. Ordnung W; Müting D Med Klin; 1980 Aug; 75(17):618-20. PubMed ID: 7412711 [TBL] [Abstract][Full Text] [Related]